ロード中...
Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness
The SARS-CoV-2 pandemic has produced an unprecedented rush to develop new therapies, ranging from immunizations and antivirals to host-directed therapies to dampen potentially deleterious host inflammatory responses. With a sense of urgency, many groups have proposed repurposing approved drugs for o...
保存先:
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305752/ https://ncbi.nlm.nih.gov/pubmed/32574958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102836 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|